Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Bliss GVS Pharma Ltd

NSE: BLISSGVS · BSE: 506197 · Pharmaceuticals & Biotechnology · 40 announcements

Share price
₹680.00
Market cap
₹7,230 Cr
Revenue (annual)
₹927.1 Cr
Net profit (annual)
₹129.1 Cr
P/E (TTM)
53.1×Sector 47.4×
Promoter holding
35.01%-0.35% QoQ
FII holding
8.07%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

10:08 IST BSE
Open Offer

Bliss GVS Pharma Open Offer: ₹0.05 Cr

Anupam Rasayan India Ltd completed an open offer to acquire 26% of Bliss GVS Pharma Ltd. Only 1,669 shares were acquired for ₹4.99 Lakh.

Value
₹0.05 Cr
19:50 IST BSE
Open Offer

Bliss GVS Pharma Open Offer: ₹829 Cr

Anupam Rasayan India Ltd has launched an open offer to acquire up to 2.77 crore shares of Bliss GVS Pharma at ₹299 per share.

Value
₹829.0 Cr
19:09 IST BSE
Open Offer

Bliss GVS Pharma Open Offer

Bliss GVS Pharma Ltd received an addendum to the open offer's public announcement, adding Mates Visa Consultancy Pvt Ltd as a Person Acting in Concert.

10:19 IST BSE
Open Offer

Bliss GVS Pharma Open Offer: ₹829 Cr

Anupam Rasayan announced a ₹829.03 Crore open offer for Bliss GVS Pharma. The acquirer seeks a 26% stake following a controlling share purchase agreement.

Value
₹829.0 Cr
11:02 IST NSE
Open Offer

Bliss GVS Pharma Open Offer: ₹805.1 Cr

Anupam Rasayan India Limited launched an ₹805.12 Crore open offer to acquire a 26% stake in Bliss GVS Pharma Limited. The offer price is set at ₹299 per share.

Value
₹805.1 Cr
19:50 IST BSE
Open Offer

Bliss GVS Pharma Open Offer: ₹829 Cr

Anupam Rasayan India Limited launched an ₹829.03 Crore open offer for Bliss GVS Pharma. The offer follows a 43.30% stake acquisition, aiming for a majority 69.51% holding.

Value
₹829.0 Cr
Execution
10 working days post-closure
22:37 IST BSE
Open Offer

Bliss GVS Pharma Open Offer: ₹829 Cr

Anupam Rasayan launched a ₹829.03 Crore open offer to acquire a 26% stake in Bliss GVS Pharma. This follows a majority acquisition trigger via agreement.

Value
₹829.0 Cr
Execution
10 working days (Tendering Period)